Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Intelgenx Technologies Corp T.IGX

Alternate Symbol(s):  IGXT

Healthcare
IntelGenx Technologies Corp. is a Canada-based drug delivery company. The Company provides single-site, end-to-end contract development and manufacturing services of oral thin film and transdermal drug products for the pharmaceutical and animal health markets, spanning the entire drug development and commercial product cycle. The Company’s film technologies, including VersaFilm, DisinteQ... see more

Recent & Breaking News (TSX:IGX)

IntelGenx Receives Final Approval to Graduate to Toronto Stock Exchange

GlobeNewswire October 5, 2021

IntelGenx and Aquestive Therapeutics Partner with Leading Men's Health Company to Market Tadalafil Oral Films in the U.S.

GlobeNewswire September 29, 2021

IntelGenx Receives U.S.$6 Million in Additional Loans from atai Life Sciences and Conditional Approval to Graduate to Toronto Stock Exchange

GlobeNewswire September 15, 2021

IntelGenx Announces Market Launch of RIZAPORT® in Spain

GlobeNewswire September 7, 2021

IntelGenx Ships CBD Filmstrips to Heritage Cannabis in Support of Canadian Market Launch

GlobeNewswire August 31, 2021

IntelGenx (TSXV:IGX) closes notes offering

John Ballem  August 5, 2021

IntelGenx Announces Closing of Notes Offering

GlobeNewswire August 5, 2021

IntelGenx Reports Second Quarter 2021 Financial Results

GlobeNewswire August 4, 2021

IntelGenx Strengthens Board with the Appointments of Dr. Srinivas G. Rao and Frank Stegert

GlobeNewswire August 4, 2021

IntelGenX to Report Second Quarter 2021 Financial Results on August 4, 2021 - Conference Call to Follow

GlobeNewswire July 29, 2021

IntelGenx Announces Subscription for Notes

GlobeNewswire July 27, 2021

IntelGenx's VetaFilm(TM) Platform to be Evaluated by One of the World's Fastest Growing Animal Healthcare Companies

GlobeNewswire June 8, 2021

IntelGenx Announces Noteholder Approval of Proposed Amendments to Convertible Notes

GlobeNewswire May 19, 2021

IntelGenx Announces Initial Closing of atai Investment

GlobeNewswire May 14, 2021

IntelGenx Reports First Quarter 2021 Financial Results

GlobeNewswire May 13, 2021

IntelGenx Expands Psychedelics Collaboration with atai Life Sciences with Signing of Second Feasibility Agreement

GlobeNewswire May 12, 2021

IntelGenx Announces Shareholder Approval of atai Investment

GlobeNewswire May 11, 2021

IntelGenx to Report First Quarter 2021 Financial Results on May 13, 2021 - Conference Call to Follow

GlobeNewswire May 6, 2021

IntelGenx Announces Intention to Amend Convertible Unsecured Promissory Notes

GlobeNewswire April 9, 2021

IntelGenx Ships First CBD Filmstrip Order to Heritage Cannabis

GlobeNewswire March 31, 2021